Magnetic Resonance Imaging (MRI) With Hyperpolarized Pyruvate (13C)
Phase 2
75
about 6.4 years
18+
Male only
1 site in CA
What this study is about
Researchers are testing whether hyperpolarized C-13 pyruvate MRI can help diagnose and monitor advanced prostate cancer. The trial will involve men with advanced prostate cancer who are receiving treatment.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Hyperpolarized C13
- 2.Undergo Magnetic Resonance Imaging (MRI)
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Mean percent change from baseline in intra-tumoral kPG within target lesion after treatment., Mean percent change from baseline in intra-tumoral kPL within target lesion after treatment. (Cohort B)
imaging
Oncology